Top Markets
#1 Islamic Coin Islamic Coin +152.61%
#2 Bitway Bitway +56.67%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +38.37%
#4 Starpower Starpower +38.35%
#5 Pons Pons +36.57%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.29%
#7 aelf aelf +23.64%
#8 SkyAI SkyAI +20.62%
#9 Ocean Protocol Ocean Protocol +16.41%
#10 Decred Decred +14.92%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
BCWORLD PHARM. Co., Ltd. BCWORLD PHARM. Co., Ltd.

BCWORLD PHARM. Co., Ltd.

200780
Rank in Stocks #29377
BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical enterprise in South... BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical enterprise in South Korea, providing a comprehensive range of medical solutions. Its extensive product portfolio addresses diverse therapeutic areas, including the musculoskeletal system, digestive health, cardiovascular disorders, and central nervous system conditions. The company also supplies adrenocorticosteroids, narcotic analgesics, erectile dysfunction therapies, wellness injections, diuretics, antitussive expectorants, vaginitis treatments, anti-tuberculosis medications, anti-emetics, antiviral and antibiotic drugs, anti-malignant tumor agents, antifungal agents, antihistamines, antidotes, and antipyretic, analgesic, and anti-inflammatory compounds. Established in 1980, the firm maintains its headquarters in Seongnam-si, South Korea.
Share Price
$2.10
Market Cap
$21.45M
Change (1 day)
-2.10%
Change (1 year)
-32.36%
Country
KR
Trade BCWORLD PHARM. Co., Ltd. (200780)

Category

Healthcare
P/E ratio for BCWORLD PHARM. Co., Ltd. (200780)
P/E ratio as of 2026 TTM: 0
According to BCWORLD PHARM. Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for BCWORLD PHARM. Co., Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 39.54 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 30.10 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 70.28 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 22.25 -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 107.81 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.